Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The Salutary Effects of Diminazene, Lisinopril or Valsartan on Cisplatin - Induced Acute Kidney Injury in Rats: A Comparative Study

YM. Al Suleimani, BH. Ali, H. Ali, P. Manoj, KS. Almashaiki, AM. Abdelrahman

. 2024 ; 73 (2) : 227-237. [pub] 20240430

Status minimální Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, srovnávací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc24009823

Nephrotoxicity as a cause of acute kidney injury (AKI) induced by cisplatin (CP), limits its usefulness as an anticancer agent. Diminazene, an angiotensin converting enzyme 2 activator, exhibited renoprotective properties on rat models of kidney diseases. This research aims to investigate the salutary effect of diminazene in comparison with lisinopril or valsartan in CP-induced AKI. The first and second groups of rats received oral vehicle (distilled water) for 9 days, and saline injection or intraperitoneal CP (6 mg/kg) on day 6, respectively. Third, fourth, and fifth groups received intraperitoneal injections of CP on day 6 and diminazene (15 mg/kg/day, orally), lisinopril (10 mg/kg/day, orally), or valsartan (30 mg/kg/day, orally), for 9 days, respectively. 24h after the last day of treatment, blood and kidneys were removed under anesthesia for biochemical and histopathological examination. Urine during the last 24 h before sacrificing the rats was also collected. CP significantly increased plasma urea, creatinine, neutrophil gelatinase-associated lipocalin, calcium, phosphorus, and uric acid. It also increased urinary albumin/creatinine ratio, N-Acetyl-beta-D-Glucosaminidase/creatinine ratio, and reduced creatinine clearance, as well the plasma concentrations of inflammatory cytokines [plasma tumor necrosis factor-alpha, and interleukin-1beta], and significantly reduced antioxidant indices [catalase, glutathione reductase , and superoxide dismutase]. Histopathologically, CP treatment caused necrosis of renal tubules, tubular casts, shrunken glomeruli, and increased renal fibrosis. Diminazine, lisinopril, and valsartan ameliorated CP-induced biochemical and histopathological changes to a similar extent. The salutary effect of the three drugs used is, at least partially, due to their anti-inflammatory and antioxidant effects. Keywords: Cisplatin, Diminazene, ACE2 activator, Lisinopril, Valsartan, Acute kidney injury.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24009823
003      
CZ-PrNML
005      
20250312151332.0
007      
ta
008      
240606s2024 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.935210 $2 doi
035    __
$a (PubMed)38710058
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Al Suleimani, Y M $u Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Al Khod, Oman, yousufm@squ.edu.om
245    14
$a The Salutary Effects of Diminazene, Lisinopril or Valsartan on Cisplatin - Induced Acute Kidney Injury in Rats: A Comparative Study / $c YM. Al Suleimani, BH. Ali, H. Ali, P. Manoj, KS. Almashaiki, AM. Abdelrahman
520    9_
$a Nephrotoxicity as a cause of acute kidney injury (AKI) induced by cisplatin (CP), limits its usefulness as an anticancer agent. Diminazene, an angiotensin converting enzyme 2 activator, exhibited renoprotective properties on rat models of kidney diseases. This research aims to investigate the salutary effect of diminazene in comparison with lisinopril or valsartan in CP-induced AKI. The first and second groups of rats received oral vehicle (distilled water) for 9 days, and saline injection or intraperitoneal CP (6 mg/kg) on day 6, respectively. Third, fourth, and fifth groups received intraperitoneal injections of CP on day 6 and diminazene (15 mg/kg/day, orally), lisinopril (10 mg/kg/day, orally), or valsartan (30 mg/kg/day, orally), for 9 days, respectively. 24h after the last day of treatment, blood and kidneys were removed under anesthesia for biochemical and histopathological examination. Urine during the last 24 h before sacrificing the rats was also collected. CP significantly increased plasma urea, creatinine, neutrophil gelatinase-associated lipocalin, calcium, phosphorus, and uric acid. It also increased urinary albumin/creatinine ratio, N-Acetyl-beta-D-Glucosaminidase/creatinine ratio, and reduced creatinine clearance, as well the plasma concentrations of inflammatory cytokines [plasma tumor necrosis factor-alpha, and interleukin-1beta], and significantly reduced antioxidant indices [catalase, glutathione reductase , and superoxide dismutase]. Histopathologically, CP treatment caused necrosis of renal tubules, tubular casts, shrunken glomeruli, and increased renal fibrosis. Diminazine, lisinopril, and valsartan ameliorated CP-induced biochemical and histopathological changes to a similar extent. The salutary effect of the three drugs used is, at least partially, due to their anti-inflammatory and antioxidant effects. Keywords: Cisplatin, Diminazene, ACE2 activator, Lisinopril, Valsartan, Acute kidney injury.
650    _2
$a zvířata $7 D000818
650    12
$a akutní poškození ledvin $x chemicky indukované $x patologie $x metabolismus $x prevence a kontrola $x farmakoterapie $7 D058186
650    12
$a lisinopril $x farmakologie $7 D017706
650    12
$a cisplatina $x toxicita $7 D002945
650    12
$a valsartan $x farmakologie $7 D000068756
650    _2
$a mužské pohlaví $7 D008297
650    12
$a diminazen $x analogy a deriváty $x farmakologie $x terapeutické užití $7 D004133
650    _2
$a krysa rodu Rattus $7 D051381
650    12
$a potkani Wistar $7 D017208
650    _2
$a protinádorové látky $x toxicita $7 D000970
650    _2
$a inhibitory ACE $x farmakologie $7 D000806
650    _2
$a ledviny $x účinky léků $x patologie $x metabolismus $7 D007668
655    _2
$a časopisecké články $7 D016428
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Ali, B H
700    1_
$a Ali, H
700    1_
$a Manoj, P
700    1_
$a Almashaiki, K S
700    1_
$a Abdelrahman, A M
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 73, č. 2 (2024), s. 227-237
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38710058 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y - $z 0
990    __
$a 20240606 $b ABA008
991    __
$a 20250312151338 $b ABA008
999    __
$a min $b bmc $g 2283486 $s 1219653
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 73 $c 2 $d 227-237 $e 20240430 $i 1802-9973 $m Physiological research $n Physiol Res $x MED00003824
LZP    __
$a Pubmed-20240606

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...